MoonLake Immunotherapeutics (MLTX)
17.69
+0.20
(+1.14%)
USD |
NASDAQ |
Jun 11, 16:00
17.41
-0.28
(-1.58%)
After-Hours: 19:42
MoonLake Immunotherapeutics EPS Diluted (Quarterly) : -0.978 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.978 |
| December 31, 2025 | -0.9212 |
| September 30, 2025 | -1.100 |
| June 30, 2025 | -0.8726 |
| March 31, 2025 | -0.6317 |
| December 31, 2024 | -0.7231 |
| September 30, 2024 | -0.5627 |
| June 30, 2024 | -0.386 |
| March 31, 2024 | -0.2183 |
| December 31, 2023 | -0.1241 |
| September 30, 2023 | -0.1761 |
| June 30, 2023 | -0.2319 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.2305 |
| December 31, 2022 | -0.3054 |
| September 30, 2022 | -0.2738 |
| June 30, 2022 | -0.3443 |
| March 31, 2022 | -3.167 |
| December 31, 2021 | -1.401 |
| September 30, 2021 | -2.630 |
| June 30, 2021 | -2.898 |
| March 31, 2021 | -0.0052 |
| December 31, 2020 | -0.0058 |
| September 30, 2020 | -0.0003 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BeOne Medicines Ltd. | 1.970 |
| AC Immune SA | -0.1914 |
| CRISPR Therapeutics AG | -1.280 |
| Idorsia Ltd. | -0.3918 |
| ADC Therapeutics SA | -0.2139 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -69.71M |
| Total Expenses (Quarterly) | 69.71M |
| Enterprise Value | 1.005B |
| Earnings Yield | -21.89% |
| Normalized Earnings Yield | -21.89 |